Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Intangibles (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Intangibles for 16 consecutive years, with $333000.0 as the latest value for Q4 2025.

  • Quarterly Intangibles fell 29.0% to $333000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $333000.0 through Dec 2025, down 29.0% year-over-year, with the annual reading at $333000.0 for FY2025, 29.0% down from the prior year.
  • Intangibles for Q4 2025 was $333000.0 at Plus Therapeutics, down from $374000.0 in the prior quarter.
  • The five-year high for Intangibles was $557000.0 in Q2 2024, with the low at $33000.0 in Q1 2024.
  • Average Intangibles over 5 years is $212789.5, with a median of $113000.0 recorded in 2022.
  • The sharpest move saw Intangibles tumbled 58.23% in 2024, then surged 1218.18% in 2025.
  • Over 5 years, Intangibles stood at $60000.0 in 2021, then surged by 56.67% to $94000.0 in 2022, then crashed by 55.32% to $42000.0 in 2023, then surged by 1016.67% to $469000.0 in 2024, then dropped by 29.0% to $333000.0 in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $333000.0, $374000.0, and $401000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.